These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6974890)
1. Significance of C-reactive protein elevation in the pretreatment stage of systemic lupus erythematosus. Inoue T; Kanayama Y; Katoh N; Ohe A; Amatsu K; Okamura M; Horiguchi T Scand J Rheumatol; 1981; 10(3):222-4. PubMed ID: 6974890 [TBL] [Abstract][Full Text] [Related]
2. Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Zein N; Ganuza C; Kushner I Arthritis Rheum; 1979 Jan; 22(1):7-12. PubMed ID: 103559 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus. Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736 [TBL] [Abstract][Full Text] [Related]
4. [Elevated C reactive protein rate in 23 black African patients with systemic lupus erythematosus and without opportunistic infectious disease]. Iba-Ba J; Biteghe B; Missounga L; Ibouili RB; Mipinda JB; Coniquet S; Kombila JB; Boguikouma JB Sante; 2009; 19(2):67-71. PubMed ID: 20031513 [TBL] [Abstract][Full Text] [Related]
5. The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus. Son CN; Lee TH; Bang JH; Jeong HJ; Chae JN; Lee WM; Kim JM; Kim SH Korean J Intern Med; 2018 Jul; 33(4):823-828. PubMed ID: 28352058 [TBL] [Abstract][Full Text] [Related]
6. Studies of serum C-reactive protein in systemic lupus erythematosus. Williams RC; Harmon ME; Burlingame R; Du Clos TW J Rheumatol; 2005 Mar; 32(3):454-61. PubMed ID: 15742436 [TBL] [Abstract][Full Text] [Related]
7. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Linares LF; Gomez-Reino JJ; Carreira PE; Morillas L; Ibero I Clin Rheumatol; 1986 Jan; 5(1):66-9. PubMed ID: 3485499 [TBL] [Abstract][Full Text] [Related]
8. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients. Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of Thyroid Autoantibodies,System Lupus Erythematosus Immunologic Indicators and Disease Activity in SLE with HT]. Liu H; Yang LH; Yin G; Xie QB Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):179-182. PubMed ID: 29737056 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271 [TBL] [Abstract][Full Text] [Related]
11. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus. Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006 [TBL] [Abstract][Full Text] [Related]
12. C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels. Delongui F; Lozovoy MAB; Iriyoda TMV; Costa NT; Stadtlober NP; Alfieri DF; Flauzino T; Dichi I; Simão ANC; Reiche EMV Clin Rheumatol; 2017 Aug; 36(8):1779-1788. PubMed ID: 28567557 [TBL] [Abstract][Full Text] [Related]
13. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371 [TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. Callen JP J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):278-88. PubMed ID: 3871800 [TBL] [Abstract][Full Text] [Related]
15. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus. Nishiya K; Hashimoto K Clin Exp Rheumatol; 1997; 15(1):39-44. PubMed ID: 9093771 [TBL] [Abstract][Full Text] [Related]
16. Can the urine dipstick test reduce the need for microscopy for assessment of systemic lupus erythematosus disease activity? Chan RW; Chow KM; Tam LS; Li EK; Wong SM; Li PK; Szeto CC J Rheumatol; 2005 May; 32(5):828-31. PubMed ID: 15868617 [TBL] [Abstract][Full Text] [Related]
17. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [TBL] [Abstract][Full Text] [Related]
18. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Suh CH; Chun HY; Ye YM; Park HS Clin Immunol; 2006 Jun; 119(3):291-6. PubMed ID: 16406714 [TBL] [Abstract][Full Text] [Related]
19. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. Blaustein DA; Blaustein SA J Rheumatol; 1998 Apr; 25(4):798-800. PubMed ID: 9558189 [TBL] [Abstract][Full Text] [Related]
20. Analysis of 15 patients with systemic lupus erythematosus manifesting with negative immunofluorescence anti-nuclear antibodies after treatment. Song LJ; Ding F; Liu HX; Shu Q; Yu X; Li J; Li XF Lupus; 2012 Jul; 21(8):919-24. PubMed ID: 22187164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]